Stockreport

Inhibikase Therapeutics Shares Up 11% Following Positive Data for Parkinson's Treatment [MarketWatch]

Inhibikase Therapeutics, Inc.  (IKT) 
PDF The stock was up 11% at $3.28 at 11:16 a.m. ET. The shares have surged 158% since the start of this year. Advertisement The clinical-stage pharmaceutical company sa [Read more]